Skip to content

Clinical trials

Urinary Incontinence, Urge trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Incontinence, Urge Country / region: United States Clear all

135 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20045
20051
20064
20072
20086
20095
20106
20114
20125
20135
20143
20153
20163
20173
201815
201912
202010
20217
20229
20237
20247
20257
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed82
Recruiting14
Terminated14
Withdrawn8
Unknown status8
Active, not recruiting5
Not yet recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Axonics, Inc.6
MedtronicNeuro6
University of California, San Francisco6
NICHD Pelvic Floor Disorders Network4
University of New Mexico4
Urovant Sciences GmbH4
Valencia Technologies Corporation4
Avation Medical, Inc.3
Laborie Medical Technologies Inc.3
Loma Linda University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Incontinence, Urge135
Urinary Bladder, Overactive79
Urinary Incontinence45
Urinary Incontinence, Stress21
Lower Urinary Tract Symptoms10
Urinary Bladder, Neurogenic7
Fecal Incontinence6
Nocturia4
Pelvic Organ Prolapse4
Urologic Diseases4

Trials

Showing 1 to 25 of 135. Each trial links to its page on Pharma Observatory.

35 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.